Boehringer Ingelheim Pharmaceuticals, Inc.
Patent Owner
Stats
- 265 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jul 28, 2015 most recent publication
Details
- 265 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 6,110 Total Citation Count
- May 29, 1984 Earliest Filing
- 103 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8741897 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereofSep 22, 04Jun 03, 14[A61K, C07D, A61P]
8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereofApr 25, 06Jul 03, 12[A61K, C07D]
7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereofJul 20, 05Apr 26, 11[C07D]
7914770 Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellantsMar 19, 04Mar 29, 11[A61K]
7795272 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereofMar 04, 05Sep 14, 10[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0178,184 T CELL PROTEINS AND NUCLEOTIDES ENCODING THE SAMEAbandonedMar 29, 12Jul 12, 12[G01N, C07K]
2012/0135,401 Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory DiseaseAbandonedMar 23, 11May 31, 12[C12Q]
2011/0301,201 DABIGATRAN FOR PERCUTANEOUS INTERVENTIONAL CARDIAC CATHETERISATIONAbandonedAug 17, 09Dec 08, 11[A61K, A61P]
2010/0234,347 Substituted Pteridines substituted with a Four-Membered HeterocycleAbandonedMay 15, 07Sep 16, 10[A61K, C07D, A61P]
2010/0136,550 Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory DiseaseAbandonedSep 25, 09Jun 03, 10[C12Q]
2010/0119,506 Effectors of PAR-2 Activation and Their Use in the Modulation of InflammationAbandonedJul 30, 09May 13, 10[A61K, A61P, C07K]
2009/0110,669 METHODS FOR IMPROVING CELL LINE ACTIVITY IN IMMUNOISOLATION DEVICESAbandonedJan 05, 09Apr 30, 09[A61K, C12N, A61P]
2009/0099,159 Method of Treating Diseases and Conditions Associated with an Altered Level of Amyloid Beta Peptides and New Enolcarboxamide CompoundsAbandonedDec 17, 08Apr 16, 09[A61K, C07D, A61P]
2009/0088,571 Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amidesAbandonedDec 05, 08Apr 02, 09[C07D, C07C]
2009/0035,321 Intercellular adhesion molecules and their binding ligandsAbandonedDec 04, 06Feb 05, 09[A61K, C07H, C12Q, C07K]
2007/0099,949 Method for Improving the Ability of Patients Suffering from Lung Diseases to Participate In and Benefit from Pulmonary Rehabilitation ProgramsAbandonedAug 31, 06May 03, 07[A61K]
2007/0032,403 Crystal structure of the ITK kinase domainAbandonedDec 23, 04Feb 08, 07[A61K, C12N, G01N, G06F]
2007/0009,498 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell linesAbandonedJan 17, 06Jan 11, 07[A61K, C07H, C12P, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
